Until recently, most pharmaceutical manufacturers have focused on fulfilling lot-level traceability and serialization compliance requirements. But in the upcoming years, there is a deadline which effects every unit of the supply chain. Before the deadline every manufacturer, distributor, hospitals and pharmacies have to adjust their systems according to 2011/62/EU Directive.
According to the results of a survey KPMG conducted, more than %70 of participants accepts the serialization ideia and take action because they think the data taken from the serialization process can help the current business process change for the better. We can say that for the ones who made large investments for serialization, they have a consciousness about the high benefits of serialization.
We can summerize the results of the survey as the following:
Participants noted that they have seen the tremendous potential for the future by creating value in specific areas. More than half of the participants (52%) view the credit calculation and routing supervision as top organizational priorities and are making plans accordingly.